NIH-funded research R21 grant

Exploring how components of breast milk can help treat brain injuries in premature infants

Official title: Investigating the therapeutic potential of maternal breast milk components for preterm white matter injury

Funded at University of California, San Francisco · NIH-11057141 · Data updated 2026-11-12

This study is looking at how certain ingredients in breast milk might help heal brain injuries in premature babies, with the hope of finding new treatments to support their brain development.

More Preterm research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 19, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$451,000
NIH project number1R21HD117430-01A1
Project IDNIH-11057141 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants who are at risk of or have been diagnosed with white matter injury.

Less likely to help

Patients who are not premature or do not have white matter injury may not benefit from this research.

What this research studies

This research investigates the potential of specific components found in maternal breast milk to treat white matter injury (WMI) in premature infants, a condition that can lead to serious neurological issues. The study employs a novel high-throughput screening method to identify beneficial compounds in breast milk, particularly focusing on their ability to promote the growth and maturation of oligodendrocytes, which are crucial for brain development. By validating these compounds through both laboratory and animal testing, the research aims to develop effective therapies for this vulnerable population.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve neurological outcomes for premature infants suffering from brain injuries.

How similar studies have gone: While this approach is innovative, previous research has shown promise in using nutritional compounds for therapeutic purposes, indicating potential for success in this area.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Chan, Jonah R — University of California, San Francisco
  • Study coordinator: Chan, Jonah R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.